Prevalence of prediabetes among adolescents and young adults in the United States, 2005-2016
Open accessAbstract
Importance: Individuals with prediabetes are at increased risk of developing type 2 diabetes, chronic kidney disease, and cardiovascular disease. The incidence and prevalence of type 2 diabetes in the US adolescent population have increased in the last decade. Therefore, it is important to monitor the prevalence of prediabetes and varying levels of glucose tolerance to assess the future risk of type 2 diabetes in the youngest segment of the population. Objective: To examine the prevalence of impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and increased glycated hemoglobin A1c (HbA1c) levels in US adolescents (aged 12-18 years) and young adults (aged 19-34 years) without diabetes. Design, Setting, and Participants: This cross-sectional analyses of the 2005-2016 National Health and Nutrition Examination Survey assessed a population-based sample of adolescents and young adults who were not pregnant, did not have diabetes, and had measured fasting plasma glucose, 2-hour plasma glucose after a 75-g oral glucose tolerance test, and HbA1c levels. Analysis began in April 2017. Main Outcomes and Measures: Impaired fasting glucose was defined as fasting plasma glucose of 100 mg/dL to less than 126 mg/dL, IGT as 2-hour plasma glucose of 140 mg/dL to less than 200 mg/dL, and increased HbA1c level as HbA1c level between 5.7% and 6.4%. The prevalence of IFG, isolated IFG, IGT, isolated IGT, increased HbA1c level, isolated increased HbA1c level, and prediabetes (defined as having IFG, IGT, or increased HbA1c level) were estimated. Fasting insulin levels and cardiometabolic risk factors across glycemic abnormality phenotypes were also compared. Obesity was defined as having age- and sex-specific body mass index (calculated as weight in kilograms divided by height in meters squared) in the 95th percentile or higher in adolescents or 30 or higher in young adults. Results: Of 5786 individuals, 2606 (45%) were adolescents and 3180 (55%) were young adults. Of adolescents, 50.6% (95% CI, 47.6%-53.6%) were boys, and 50.6% (95% CI, 48.8%-52.4%) of young adults were men. Among adolescents, the prevalence of prediabetes was 18.0% (95% CI, 16.0%-20.1%) and among young adults was 24.0% (95% CI, 22.0%-26.1%). Impaired fasting glucose constituted the largest proportion of prediabetes, with prevalence of 11.1% (95% CI, 9.5%-13.0%) in adolescents and 15.8% (95% CI, 14.0%-17.9%) in young adults. In multivariable logistic models including age, sex, race/ethnicity, and body mass index, the predictive marginal prevalence of prediabetes was significantly higher in male than in female individuals (22.5% [95% CI, 19.5%-25.4%] vs 13.4% [95% CI, 10.8%-16.5%] in adolescents and 29.1% [95% CI, 26.4%-32.1%] vs 18.8% [95% CI, 16.5%-21.3%] in young adults). Prediabetes prevalence was significantly higher in individuals with obesity than in those with normal weight (25.7% [95% CI, 20.0%-32.4%] vs 16.4% [95% CI, 14.3%-18.7%] in adolescents and 36.9% [95% CI, 32.9%-41.1%] vs 16.6% [95% CI, 14.2%-19.4%] in young adults). Compared with persons with normal glucose tolerance, adolescents and young adults with prediabetes had significantly higher non-high-density lipoprotein cholesterol levels, systolic blood pressure, central adiposity, and lower insulin sensitivity (P < .05 for all). Conclusions and Relevance: In the United States, about 1 of 5 adolescents and 1 of 4 young adults have prediabetes. The adjusted prevalence of prediabetes is higher in male individuals and in people with obesity. Adolescents and young adults with prediabetes also present an unfavorable cardiometabolic risk profile, putting them both at increased risk of type 2 diabetes and cardiovascular diseases.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
It is estimated that one in five adolescents and one in four young adults now have impaired glucose tolerance and/or impaired fasting glucose in the U.S., which increases the risks of progression to type 2 diabetes, CKD, and cardiovascular complications.
“It is estimated that one in fi ve adolescents and one in four young adults now have impaired glucose tolerance and/or impaired fasting glucose in the U.S., which in turn increases the risks of progression to type 2 diabetes, CKD, and cardiovascular complications (267).”
From Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2022) · cites this paper as [267]
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredRates of impaired glucose tolerance and/or impaired fasting glucose and type 2 diabetes have increased significantly in the adolescent and young adult population, in concert with increases in obesity.
“Rates of impaired glucose tolerance and/ or impaired fasting glucose and type 2 diabetes have increased signi fi cantly in the adolescent and young adult population, in concert with increases in obesity (267).”
From Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2022) · cites this paper as [267]
The Abstract (page not provided) reports that type 2 diabetes incidence and prevalence have increased among US adolescents. It also finds prediabetes more prevalent in adolescents and young adults with obesity. It does not establish that IFG or IGT rates increased significantly over time, that type 2 diabetes increased among young adults, or that these changes occurred in concert with rising obesity. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · see citing works
Density Estimation for Statistics and Data Analysis
Silverman, B. W. (2018) · Routledge eBooks · doi:10.1201/9781315140919 · Cited by 15,938 · see citing works
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · see citing works
Density Estimation for Statistics and Data Analysis
(1986) · Springer eBooks · doi:10.1007/978-1-4899-3324-9 · Cited by 8,478 · see citing works
CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000
Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Strawn, L. G., Flegal, K. M., & Mei, Z. (2002) · Cited by 6,426 · see citing works
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320 · see citing works
2000 CDC Growth Charts for the United States: methods and development.
Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Grummer‐Strawn, L. M., Flegal, K. M., Mei, Z., Wei, R. X., Curtin, L. R., Roche, A. F., & Johnson, C. L. (2002) · PubMed · Cited by 3,716 · see citing works
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
Menke, A., Casagrande, S., Geiss, L., & Cowie, C. C. (2015) · JAMA · doi:10.1001/jama.2015.10029 · Cited by 2,362 · see citing works
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881 · see citing works
Hales, C. M., Fryar, C. D., Carroll, M. D., Freedman, D. S., & Ogden, C. L. (2018) · JAMA · doi:10.1001/jama.2018.3060 · Cited by 1,761 · see citing works
Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012
Mayer-Davis, E. J., Lawrence, J. M., Dabelea, D., Divers, J., Isom, S., Dolan, L., Imperatore, G., Linder, B., Marcovina, S., Pettitt, D. J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610187 · Cited by 1,476 · see citing works
Self-citationHuang, Y., Cai, X., Mai, W., Li, M., & Hu, Y. (2016) · BMJ · doi:10.1136/bmj.i5953 · Cited by 1,012 · see citing works
Predictive Margins with Survey Data
Graubard, B. I., & Korn, E. L. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00652.x · Cited by 875 · see citing works
Abdul-Ghani, M. A., Tripathy, D., & DeFronzo, R. A. (2006) · Diabetes Care · doi:10.2337/dc05-2179 · Cited by 744 · see citing works
Dabelea, D., Stafford, J. M., Mayer-Davis, E. J., D’Agostino, R., Dolan, L., Imperatore, G., Linder, B., Lawrence, J. M., Marcovina, S. M., Mottl, A. K., et al. (2017) · JAMA · doi:10.1001/jama.2017.0686 · Cited by 700 · see citing works
Self-citationAge- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts
The DECODE Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.1.61 · Cited by 608 · see citing works
Herman, W. H., Ma, Y., Uwaifo, G., Haffner, S., Kahn, S. E., Horton, E. S., Lachin, J. M., Montez, M. G., Brenneman, T., Barrett-Connor, E., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2003 · Cited by 574 · see citing works
Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Population Aged <20 Years Through 2050
Imperatore, G., Boyle, J. P., Thompson, T. J., Case, D., Dabelea, D., Hamman, R. F., Lawrence, J. M., Liese, A. D., Liu, L. L., Mayer‐Davis, E. J., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0669 · Cited by 485 · see citing works
Self-citationEstimating Model-Adjusted Risks, Risk Differences, and Risk Ratios From Complex Survey Data
Bieler, G. S., Brown, G. G., Williams, R. L., & Brogan, D. J. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwp440 · Cited by 461 · see citing works
Bell, J. A., Mika Kivimaki, B., & Hamer, M. (2014) · Obesity Reviews · doi:10.1111/obr.12157 · Cited by 455 · see citing works
Tripathy, D., Carlsson, M., Almgren, P., Isomaa, B., Taskinen, M., Tuomi, T., & Groop, L. (2000) · Diabetes · doi:10.2337/diabetes.49.6.975 · Cited by 361 · see citing works
Ziemer, D. C., Kolm, P., Weintraub, W. S., Vaccarino, V., Rhee, M. K., Twombly, J. G., Narayan, K. M. V., Koch, D. D., & Phillips, L. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-12-201006150-00004 · Cited by 326 · see citing works
Meyer, C., Pimenta, W., Woerle, H. J., Van Haeften, T., Szoke, E., Mitrakou, A., & Gerich, J. (2006) · Diabetes Care · doi:10.2337/dc06-0438 · Cited by 308 · see citing works
Bergenstal, R. M., Gal, R. L., Connor, C. G., Gubitosi-Klug, R., Kruger, D., Olson, B. A., Willi, S. M., Aleppo, G., Weinstock, R. S., Wood, J., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2596 · Cited by 306 · see citing works
Prevalences of Diabetes and Impaired Glucose Regulation in a Danish Population
Glümer, C., Jørgensen, T., & Borch-Johnsen, K. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2335 · Cited by 279 · see citing works
Saito, T. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.275 · Cited by 277 · see citing works
Resurgence in Diabetes-Related Complications
Gregg, E. W., HORA, I. A., & Benoit, S. R. (2019) · JAMA · doi:10.1001/jama.2019.3471 · Cited by 257 · see citing works
Self-citationFærch, K., Borch‐Johnsen, K., Holst, J. J., & Vaag, A. A. (2009) · Diabetologia · doi:10.1007/s00125-009-1443-3 · Cited by 255 · see citing works
Markolf Hanefeld, E., Koehler, C., Fuecker, K., Henkel, E., Schäper, F., & Temelkova-Kurktschiev, T. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.868 · Cited by 238 · see citing works
Morris, D. H., Khunti, K., Achana, F., Srinivasan, B., Gray, L. J., Davies, M. J., & Webb, D. (2013) · Diabetologia · doi:10.1007/s00125-013-2902-4 · Cited by 229 · see citing works
Bonds, D. E., Lasser, N. L., Qi, L., Brzyski, R. G., Caan, B. J., HEISS, G. M., Limacher, M. C., LIU, J. H., Mason, E. D., Oberman, A., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0096-0 · Cited by 214 · see citing works
Festa, A., D’Agostino, R., Hanley, A. J. G., Karter, A. J., Saad, M. F., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1549 · Cited by 180 · see citing works
Blake, D. R., Meigs, J. B., Muller, D. C., Najjar, S. S., Andres, R., & Nathan, D. M. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2095 · Cited by 169 · see citing works
Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012
Bullock, A., & Sheff, K. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1706291 · Cited by 166 · see citing works
5. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc18-s005 · Cited by 158 · see citing works
Williams, J. W., Zimmet, P. Z., Shaw, J. E., De Courten, M. P., Cameron, A. J., Chitson, P., Tuomilehto, J., & Alberti, K. G. M. M. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01059.x · Cited by 148 · see citing works
Paulmichl, K., Hatunic, M., Højlund, K., Jotić, A., Krebs, M., Mitrakou, A., Porcellati, F., Tura, A., Bergsten, P., Forslund, A. H., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.257436 · Cited by 143 · see citing works
Impaired glucose tolerance and fasting hyperglycaemia have different characteristics
Davies, M. J., Raymond, N. T., Day, J., Hales, C. N., & Burden, A. C. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00246.x · Cited by 132 · see citing works
From Pre-Diabetes to Type 2 Diabetes in Obese Youth
Bacha, F., Lee, S., Gungor, N., & Arslanian, S. (2010) · Diabetes Care · doi:10.2337/dc10-0004 · Cited by 127 · see citing works
The Clinical Use of Hemoglobin A1c
Saudek, C. D., & Brick, J. C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300402 · Cited by 118 · see citing works
Novoa, F. J., Boronat, M., Saavedra, P., Díaz-Cremades, J., Varillas, V. F., Roche, F. L., Alberiche, M., & Carrillo, A. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2388 · Cited by 117 · see citing works
Balion, C. M., Raina, P. S., Gerstein, H. C., Santaguida, P. L., Morrison, K. M., Booker, L., & Hunt, D. L. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.505 · Cited by 107 · see citing works
An, Y., Zhang, P., Wang, J., Gong, Q., Gregg, E. W., Yang, W., Li, H., Zhang, B., Shuai, Y., Chen, Y., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2498 · Cited by 99 · see citing works
Self-citationFretts, A. M., Howard, B. V., McKnight, B., Duncan, G. E., Beresford, S. A. A., Calhoun, D., Kriska, A. M., Storti, K. L., & Siscovick, D. S. (2012) · Diabetes Care · doi:10.2337/dc11-2321 · Cited by 78 · see citing works
Meigs, J. B. (2003) · BMJ · doi:10.1136/bmj.327.7406.61 · Cited by 77 · see citing works
Prevalence of Diabetes in Adolescents Aged 12 to 19 Years in the United States, 2005-2014
Menke, A., Casagrande, S. S., & Cowie, C. C. (2016) · JAMA · doi:10.1001/jama.2016.8544 · Cited by 77 · see citing works
van Genugten, R. E., Utzschneider, K. M., Tong, J., Gerchman, F., Zraika, S., Udayasankar, J., Boyko, E. J., Fujimoto, W. Y., Kahn, S. E., & and the American Diabetes Association GENNID Study Group (2006) · Diabetes · doi:10.2337/db06-0577 · Cited by 73 · see citing works
Prediabetes in youths: mechanisms and biomarkers
Weiss, R., Santoro, N., Giannini, C., Galderisi, A., Umano, G. R., & Caprio, S. (2017) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(17)30044-5 · Cited by 67 · see citing works
Decreased β-Cell Function in Overweight Latino Children With Impaired Fasting Glucose
Weigensberg, M. J., Ball, G. D. C., Shaibi, G. Q., Cruz, M. L., & Goran, M. I. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2519 · Cited by 65 · see citing works
Zhang, X., Imperatore, G., Thomas, W., Cheng, Y. J., Lobelo, F., Norris, K. L., Devlin, H. M., Ali, M. K., Gruss, S. M., Bardenheier, B. H., et al. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.11.020 · Cited by 61 · see citing works
Self-citationFærch, K., Johansen, N. B., Witte, D. R., Lauritzen, T., Jørgensen, M. E., & Vistisen, D. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2853 · Cited by 57 · see citing works
Galderisi, A., Giannini, C., Weiss, R., Kim, G. E., Shabanova, V., Santoro, N., Pierpont, B. M., Savoye, M., & Caprio, S. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30235-9 · Cited by 51 · see citing works
Impact of Glucose Tolerance Status, Sex, and Body Size on Glucose Absorption Patterns During OGTTs
Færch, K., Pacini, G., Nolan, J. J., Hansen, T. F., Tura, A., & Vistisen, D. (2013) · Diabetes Care · doi:10.2337/dc13-0592 · Cited by 47 · see citing works
Punthakee, Z., Alméras, N., Després, J., Dagenais, G. R., Anand, S. S., Hunt, D. L., Sharma, A. M., Jung, H. S., Yusuf, S., & Gerstein, H. C. (2014) · Diabetic Medicine · doi:10.1111/dme.12512 · Cited by 39 · see citing works
LACY, M. E., Wellenius, G. A., Carnethon, M. R., Loucks, E. B., Carson, A. P., Luo, X., Kiefe, C. I., Gjelsvik, A., Gunderson, E. P., Eaton, C. B., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0509 · Cited by 35 · see citing works
Prediction of Type 2 Diabetes by Hemoglobin A1c in Two Community-Based Cohorts
Leong, A., Daya, N. R., Porneala, B., Devlin, J. J., Shiffman, D., McPhaul, M. J., Selvin, E., & Meigs, J. B. (2017) · Diabetes Care · doi:10.2337/dc17-0607 · Cited by 27 · see citing works
Sampson, M., Elwell-Sutton, T., Bachmann, M. O., Clark, A., Dhatariya, K., Ferns, C., Howe, A. C., John, W. G., Rayman, G. A., Swafe, L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24662-y · Cited by 20 · see citing works
Cardiovascular risk factors in adolescents with prediabetes
Casagrande, S. S., Menke, A., Linder, B., Osganian, S. K., & Cowie, C. C. (2018) · Diabetic Medicine · doi:10.1111/dme.13661 · Cited by 19 · see citing works
Vijayakumar, P., Hoyer, A., Nelson, R. G., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171027 · Cited by 17 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300 · see citing works
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987 · see citing works
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104 · see citing works
Definition and diagnostic criteria of clinical obesity
Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00316-4 · Cited by 1,811 · see citing works
Self-citationHampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., Avila Edwards, K. C., Eneli, I., Hamre, R., Joseph, M. M., et al. (2023) · Pediatrics · doi:10.1542/peds.2022-060640 · Cited by 1,389 · see citing works
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048 · see citing works
Laredo-Aguilera, J. A., Gallardo-Bravo, M., Rabanales-Sotos, J. A., Cobo-Cuenca, A. I., & Carmona-Torres, J. M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176151 · Cited by 125 · see citing works
Cardiovascular and Kidney Outcomes Across the Glycemic Spectrum
Honigberg, M. C., Zekavat, S. M., Pirruccello, J. P., Natarajan, P., & Vaduganathan, M. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.004 · Cited by 108 · see citing works
Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update
Pedersen, S. D., Manjoo, P., Dash, S., Jain, A., Pearce, N., & Poddar, M. (2025) · Canadian Medical Association Journal · doi:10.1503/cmaj.250502 · Cited by 78 · see citing works
Anand, P., Bhurji, N., Williams, N., & Desai, N. (2021) · Journal of Primary Care & Community Health · doi:10.1177/21501327211053750 · Cited by 49 · see citing works
Development of type 2 diabetes in adolescent girls with polycystic ovary syndrome and obesity
Hudnut‐Beumler, J., Kaar, J. L., Taylor, A., Kelsey, M. M., Nadeau, K. J., Zeitler, P., Snell‐Bergeon, J., Pyle, L., & Cree‐Green, M. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13206 · Cited by 46 · see citing works
Monaghan, M., Mara, C. A., Kichler, J. C., Westen, S. C., Rawlinson, A., Jacobsen, L. M., Adams, R. N., Stone, J. Y., Hood, K. K., & Mulvaney, S. A. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.01.011 · Cited by 17 · see citing works
Is the Current Lifestyle Modification Approach to Diabetes Prevention in the U.S. a Success?
Echouffo-Tcheugui, J. B., Chakkalakal, R. J., & Ali, M. K. (2025) · Diabetes Care · doi:10.2337/dci24-0040 · Cited by 11 · see citing works
- Authors
- Andes, L. J., Cheng, Y. J., Rolka, D. B., Gregg, E. W., & Imperatore, G.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Imperial College London (GB)
- Corresponding author
- Andes, Linda J.
- Venue
- JAMA Pediatrics
- Publisher
- American Medical Association (AMA)
- Published
- 2020-02-03
- Volume
- 174
- Issue
- 2
- Pages
- e194498
- ISSN
- 1072-4710 (ISSN-L)
- 2168-6203
- PMC
- PMC6902249
- OpenAlex
- W2991197074
- Cited by
- 380
- References
- 59
- Citations by year
- 2026: 47 · 2025: 57 · 2024: 50 · 2023: 72 · 2022: 74 · 2021: 41 · 2020: 36 · 2017: 1
- FWCI
- 30.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Archives of Pediatrics and Adolescent Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- prediabetes, adolescents, young adults, impaired fasting glucose, impaired glucose tolerance, HbA1c, type 2 diabetes risk, obesity, cardiometabolic risk factors, fasting insulin, insulin resistance, insulin sensitivity, insulin secretion, prevalence trends, NHANES, body mass index, cardiovascular risk, chronic kidney disease risk
- MeSH terms
- Adolescent, Adult, Blood Glucose, Child, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Male, Prediabetic State, Time Factors, United States, Prevalence, Glucose Intolerance, Risk Assessment, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review